In the News… $3 Semaglutide?, New Stem Cell Partnership, “Lyla’s Law” Debate, Patient-Led Insulin Dosing in Pregnancy, FDA GLP-1 Crackdown, and more!

DC1, In the NewsLeave a comment

It’s In the News, a look at the top headlines and stories in the diabetes community. This week’s top stories: Stem Cell Islet Therapy Partnership, “Lyla’s Law” Type 1 Testing Debate, Patient-Led Insulin Dosing for Gestational Diabetes, $3 Semaglutide Manufacturing, FDA GLP-1 Compounding Crackdown Announcing Community Commericals! Learn how to get your message on the show…

In the News… Islet cell transplants update, implantable insulin pump moves forward, Olympics monitored GLP-1s and more!

DC1Leave a comment

It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: big updates for stem cell and islet transplants, new pen option for Zepbound, an implantable insulin pump moves forward and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more…

“It’s incredibly exciting” – What’s next for Tidepool with CEO Brandon Arbiter

DC1, education/resources, living with T1DLeave a comment

Tidepool was founded in 2013, part of the incredible era of DIY diabetes progress, and has since helped change how hundreds of thousands of people with diabetes see and use their data. I’m talking to CEO Brandon Artibter about how open-source innovation became FDA-cleared technology, and what’s next.. including a new partnership with Oura Ring…

In the News… Trump RX, T1D at the Olympics & Superbowl, Ozempic pill launches soon, and more!

DC1, In the NewsLeave a comment

It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: T1D in the Olympics & Superbowl, Trump RX goes live, Ozempic pill available soon, tech updates from Medtronic, Beta Bionics, Eversense 365 and more! Announcing Community Commericals! Learn how to get your message on the show…

The FDA pulled it, but the diabetes community wouldn’t let it go. How the T1D1 app made a comeback

advocate, DC1, technology and toolsLeave a comment

Two years ago the FDA pulled down just about every insulin calculator app. A lot of them just disappeared, rather than seek official approval, but one of them – created by a teenager with type 1 – is back. I’m talking with Drew and Mike Mendelow about the relaunch of T1D1, a free and ad-free insulin-dose…

In the News… Universal T1D screening studied, Dexcom new product, Afrezza prescribing guidelines update, and more!

DC1, In the NewsLeave a comment

It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: UK looks at starting universal T1D screening, Dexcom’s CEO mentions a new product, bariatric sugery vs GLP medications, FDA approves update to prescribing info for inhaled insulin, miscroplastic and diabetes link studied, and more! Announcing…

In the News… New islets study, Tzield for babies, MiniMed Go approved, Civica insulin launched, and more!

DC1, In the NewsLeave a comment

It’s In the News… the top diabetes stories and headlines happening now! Top stories this week include: new islet encapsulation trial, FDA agrees to review Tzield for babies and approves the MiniMed Go, Civica releases it’s version of Lantus, Eversense launches with a pump partner, scholarship for college students with diabetes and more! Announcing Community…